Vanguard Group »

Sonnet Biotherapeutc Hldng I shares owned by Vanguard Group

Quarter-by-quarter ownership of Sonnet Biotherapeutc Hldng I (SONN) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Sonnet Biotherapeutc Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Sonnet Biotherapeutc Hldng I held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sonnet Biotherapeutc Hldng I by Vanguard Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $14k 15k 0.94
2024-03-31 $27k 15k 1.86
2023-12-31 $26k 15k 1.74
2023-09-30 $42k 15k 2.87

More positions owned by Vanguard Group

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Eli Lilly & Co. (LLY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
Exxon Mobil Corporation (XOM)
Tesla Motors (TSLA)
UnitedHealth (UNH)
Visa Com Cl A (V)

View all positions for Vanguard Group

Top funds holding Sonnet Biotherapeutc Hldng I

Armistice Capital
Vanguard Group
Tower Research Capital
BlackRock
Morgan Stanley

View all funds holding Sonnet Biotherapeutc Hldng I